A leading American medical journal has published an article stating that the rate of severe allergic reactions with the new coronavirus vaccine, which is being inoculated in Europe and the United States, is about 1 in 100,000 so far.
It is said that such safety-related events are almost inevitable when large-scale inoculation is performed, and it is necessary to continue to carefully assess safety and disclose information.
Experts such as Harvard University in the United States have said that when about 2 million people have been vaccinated with the vaccine developed by the American pharmaceutical giant Pfizer, the rate of showing symptoms of severe allergic reaction "anaphylaxis" is about 1 in 100,000. A review article on human beings has been published in the New England Journal of Medicine.
Some say that this information has made some people feel uneasy about the new vaccine, while the symptoms of anaphylaxis are rare with other vaccines and are treatable and unaffected.
On top of that, safety-related events are almost inevitable when inoculating millions of people, and information is carefully determined so that people do not hesitate to trust the vaccine. It is said that it is necessary to proceed while publishing.